General Information of the Compound
Compound ID
CP0128144
Compound Name
2-[5-(3-Nitro-phenyl)-[1,2,4]oxadiazol-3-yl]-pyridine
    Show/Hide
Structure
Formula
C13H8N4O3
Molecular Weight
268.232
Canonical SMILES
[O-][N+](=O)c1cccc(c1)-c1nc(no1)-c1ccccn1
    Show/Hide
InChI
InChI=1S/C13H8N4O3/c18-17(19)10-5-3-4-9(8-10)13-15-12(16-20-13)11-6-1-2-7-14-11/h1-8H
    Show/Hide
InChIKey
YYKRPCBJFTUNFZ-UHFFFAOYSA-N
CAS
5799-85-9
Physicochemical Property
logP
2.7068
Rotatable Bonds
3
Heavy Atom Count
20
Polar Areas
94.95
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
6
Complexity
20

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 867096
SID: 14823986
ChEMBL ID
CHEMBL1466899
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00854, Metabotropic glutamate receptor 5
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 236 nM
   TI
   LI
   LO
   TS